Avelle^™ Clinical Evidence

The Avelle™ System in Practice: Case Studies

Closed Surgical Incision

 Patient

• 45-year-old female.
• BMI of >35.
• Breast cancer patient – mastectomy with immediate breast reconstruction using a total latissimus dorsi flap.

Wound

• 21 cm surgical wound. Skin closed stitched with resorbable subcuticular sutures.
• The wound broke down and was measured at (L) 6 cm x (W) 2 cm with extensive undermining.

Management & Results

• Avelle™ NPWT System with the 12x31cm dressing applied on day 2, and the dressing was changed on days 5, 7 and 10 postoperatively, at which point NPWT discontinued.
• The wound showed improvement, measuring (L) 6 cm x (W) 1.5 cm, exudate in the drain remained stable. The wound had dried up; dead tissue had been successfully debrided and the peri-wound skin was less purple.

Dehisced Abdominal Wound

Patient

• 56-year-old male.
• BMI of >35 underwent surgery for ulcerated diverticulitis with peritonitis.

Wound

• Grade 1 dehisced surgical wound.
• Wound measured 22 cm in length at the start of therapy.

Management & Results

• The Avelle™ NPWT System was applied for a 30-day period with 8 dressing changes.
• The wound had signifi cantly reduced in size at the end of the 30-day therapy period.

_________________________________________

In a multi-center evaluation of 92 patients treated with the Avelle™ NPWT System¹: